
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United Kingdom), United Kingdom, covering academic research published from 2010 to 2025. Read More.
Open Access Percentage
75%
Total
Publications
151
Total Open
Publications
113
Total
Citations
3K
Open Access
Percentage
75%
Total
Publications
151
Total Open
Publications
113
Total
Citations
3K
Breakdown
Publisher Open
26%
Both
48%
Other Platform Open
1%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 50%
56
Hybrid 29%
32
No Guarantees 21%
23
Other Platform Open
Institution 73%
54
Domain 65%
48
Other Internet 12%
9
Preprint 1%
1
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 48 |
doaj.org OAI-PMH Repository | Institution | 40 |
Unknown Repository | Other Internet | 8 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
LA Referencia | Institution | 4 |
DOI | Other Internet | 4 |
University of Manchester | Institution | 3 |
The University of Melbourne | Institution | 3 |
Europe PMC | Domain | 3 |
California Digital Library | Institution | 3 |